Piper Jaffray's Healthcare team highlighted 14 names to buy on the recent weakness in the biopharma sector while highlighting one ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE